Home

Site map

Contacts
рус
eng
Search



You can subscribe for news mailing

Media partners:
Новый канал ICTV
СТБ М1
Korrespondent.net obozrevatel.com
META  
Home / Programs & Projects / Clinton Foundation / The partnership with Clinton HIV/AIDS Initiative (CHAI)
Clinton Foundation
17.09.2004
The partnership with Clinton HIV/AIDS Initiative (CHAI)

After learning about Clinton Foundation unique approach, Elena Franchuk has initiated the negotiations between Clinton HIV/AIDS Initiative and Ukraine in order to facilitate the access to ARV-treatment and laboratory equipment on the lowest possible prices. After sharing the information about Ukraine and a real need of people living with HIV/AIDS the representative of Clinton HIV/AIDS Procurement Consortium has visited Ukraine on the official invitation of Elena Franchuk ANTIAIDS Foundation. On September 15th the Minister of health of Ukraine Andrey Pidaev has signed the Memorandum of understanding with Clinton HIV/AIDS Initiative and Ukraine become the member of Clinton HIV/AIDS Procurement Consortium.

One of the main directions of the Clinton HIV/AIDS Initiative founded by the 42nd USA President is rendering the assistance to the most effected by the epidemic countries by reducing the costs of treatment and diagnostics of HIV-positive and people who have AIDS. Ukraine now can obtain 60% discount on ARV-treatments vitally necessary for thousands people and 80% discount on laboratory equipment owing to the partnership with Clinton Initiative.

The prices available for Clinton HIV/AIDS Initiative member countries are made as the result of negotiations with the leading ARV-treatment merchants about co-ordination and planning of their delivery worldwide. For outstanding merchants this provides new distribution channels and market forecasting. For the consumers this provides special pricing inaccessible under other conditions. As the results of the efforts made the prices for the most spread HIV/AIDS treatment cut down at 40-60% from their cost on the world market. The tests costs for virus determining falls on 80% meanwhile CD4 test decreases in 5-8 times. These are the most necessary tests for providing and controlling efficient ARV therapy.  

Clinton HIV/AIDS Initiative supports the member countries in planning and analysis of the ARV-treatment purchasing programs. This includes rendering of the technical assistance in treatment procurement, quality control as well as legal help in patent legislation.

The main partners of Clinton HIV/AIDS Initiative in ARV-treatment procurement are Cipla, Ranbaxy, Hetero and Aspen. Beckton Dickinson, Beckman Coulter, Roche, Bayer, BioMerieux are the partners in testing of ARV-treatment. The cooperation of Clinton HIV/AIDS Initiative with any ARV-treatment producer is possible only after WHO prequalification procedures. Among the partners of Clinton Initiative are a lot of international institutions such as UNICEF, WHO, World Bank and Global Fund to fight AIDS, Tuberculosis and Malaria.

Download presentation (pdf, 1,60 Mb)


© 2004-2010 Elena Pinchuk ANTIAIDS Foundation
If information from this website is reprinted, mentioning ANTIAIDS Foundation is required (for internet edition hyperlink is required)
Parus Business Centre
Mechnikova str., 2, 17th floor
01601, Kyiv, Ukraine
Phone:   +380 44 490 4805
Fax: +380 44 490 4885
Email: info@antiaids.org
site developed by